Ascendis Pharma A/S (ASND)

220.42 +10.26 (+4.88%) USD  |  NASDAQ  |  Dec 12, 16:00
220.58 +0.16 (+0.07%) After-Hours: 20:00
More

Ascendis Pharma EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Evaxion AS --
Novo Nordisk A/S --
DBV Technologies SA --
Cellectis SA --
Biodexa Pharmaceuticals Plc --